Evidence map›Paper›PMID 27378450›Full record

ArticleParasites & vectors2016

Evaluation of protective efficacy induced by virus-like particles containing a Trichinella spiralis excretory-secretory (ES) protein in mice.

Su-Hwa Lee, Sang-Soo Kim, Dong-Hun Lee, Ah-Ra Kim, Fu-Shi Quan

Abstract readEvaluation Study
In one paragraph

Article in Parasites & vectors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Phenotypic Changes ofHelminthologia · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Su-Hwa LeeDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, South Korea.
Sang-Soo KimDepartment of Medical Zoology, Kyung Hee University School of Medicine, Seoul, South Korea.
Dong-Hun LeeDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, South Korea.
Ah-Ra KimDepartment of Biomedical Science, Graduate School, Kyung Hee University, Seoul, South Korea.
Fu-Shi QuanDepartment of Medical Zoology, Kyung Hee University School of Medicine, Seoul, South Korea. fsquan@khu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe frequent outbreaks of human trichinellosis globally underscore the need to develop effective vaccine. We hypothesized that a novel vaccine could improve vaccine efficacy against Trichinella spiralis.

methodsIn this study, we developed virus-like particles (VLPs) containing the 53 KDa excretory/secretory (ES) protein of T. spiralis and the influenza matrix protein 1 (M1) as a core protein, and investigated the protective efficacy of the VLPs alone or with cholera toxin (CT) in a mouse model.

resultsIntramuscular immunization induced T. spiralis-specific IgG, IgG1 and IgG2a antibody responses before and after challenge infections in the sera. These antibody responses were significantly enhanced in mice immunized with adjuvanted VLPs. Upon challenge infection, vaccinated mice showed significantly reduced worm burden in the diaphragm. Protective immune responses and efficacy of protection were significantly improved by immunization with VLPs together with CT adjuvant.

conclusionsOur results are informative for a better understanding of the protective immunity induced by T. spiralis VLPs, and will provide insight into designing safe and effective vaccines.

Indexed as

Adjuvants, ImmunologicAnimalsAntibodies, HelminthAntigens, HelminthCholera ToxinDisease Models, AnimalFemaleHelminth ProteinsHumansImmunizationImmunoglobulin GMiceMice, Inbred BALB CTrichinella spiralisTrichinellosisVaccines, Virus-Like ParticleAdjuvants, ImmunologicAntibodies, HelminthAntigens, HelminthCholera Toxinexcretory-secretory antigen, TrichinellaHelminth ProteinsImmunoglobulin GVaccines, Virus-Like ParticleCholera toxinProtectionTrichinella spiralisVaccineVirus-like particle

Identifiers

PMID27378450
PMCPMC4932752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.